Denka Company Limited
Stock Price Chart
2026/03/03 UpdatedPrice Trend
2026/03/03 UpdatedPrice & Trading Details
2026/03/03 UpdatedPRICE
TRADING
Analyst Recommendations 7 analysts
Updated 2026/03/01Shareholder Composition
Updated 2026/03/01Dividend History 1Years Growth
Updated 2026/03/01| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥100 | +11.1% |
| 2024 | ¥90 | 0.0% |
| 2023 | ¥90 | -37.9% |
| 2022 | ¥145 | +7.4% |
| 2021 | ¥135 | - |
Financial Performance
2026/03/01 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥384,849M | ¥407,559M | ¥389,263M | ¥400,251M |
| Gross Profit | ¥107,175M | ¥102,342M | ¥82,501M | ¥84,595M |
| Operating Income | ¥40,124M | ¥32,325M | ¥13,377M | ¥14,413M |
| Pretax Income | ¥35,557M | ¥15,747M | ¥16,166M | -¥14,990M |
| Net Income | ¥26,012M | ¥12,768M | ¥11,947M | -¥12,300M |
| EPS | ¥301.67 | ¥148.08 | ¥138.61 | -¥142.73 |
| Operating Margin | 10.43% | 7.93% | 3.44% | 3.60% |
| Balance Sheet | ||||
| Total Assets | ¥557,640M | ¥592,151M | ¥616,239M | ¥655,517M |
| Total Equity | ¥288,470M | ¥296,479M | ¥307,536M | ¥296,181M |
| Total Liabilities | ¥269,170M | ¥295,672M | ¥308,703M | ¥359,336M |
| Cash | ¥20,210M | ¥20,199M | ¥35,386M | ¥37,002M |
| Interest-bearing Debt | ¥137,031M | ¥169,729M | ¥174,368M | ¥217,679M |
| Equity Ratio | 51.73% | 50.07% | 49.91% | 45.18% |
| D/E Ratio | 0.48 | 0.57 | 0.57 | 0.73 |
| Cash Flow | ||||
| Operating CF | ¥42,630M | ¥8,946M | ¥36,260M | ¥18,620M |
| Investing CF | -¥36,839M | -¥28,268M | -¥22,572M | -¥59,586M |
| Financing CF | -¥12,341M | ¥18,361M | ¥712M | ¥40,118M |
| Free CF | ¥4,676M | -¥30,894M | -¥8,419M | -¥41,210M |
| Efficiency | ||||
| ROE | 9.02% | 4.31% | 3.88% | -4.15% |
| ROA | 4.66% | 2.16% | 1.94% | -1.88% |
Latest IR Information
-
Commencement of Consideration for the Spin-off of the Styrene-related Business
Denka Company Limited has commenced consideration of a spin-off of its styrene-related business targeting April 2027, aiming to enhance business value and establish a nimble decision-making structure.
Read more -
February 27, 2026 Management Briefing Material Management Plan 'Mission 2030' Phase 2 (Fiscal Years 2026–2028)
Denka announced its Phase 2 management plan for fiscal years 2026 to 2028 targeting operating income of 45 billion yen and ROE of 8.0%, promoting strategic investments and strengthening profitability.
Read more -
Announcement on Formulation of Management Plan 'Mission 2030' Phase 2 (Fiscal Years 2026–2028)
Denka has formulated Phase 2 of its management plan for fiscal years 2026 to 2028, targeting operating income of 35 billion yen to 45 billion yen and ROE of 6.0% to 8.0%, aiming to balance growth strategies with financial discipline.
Read more -
Fiscal Year Ending March 2026 Q3 Financial Summary [Japanese GAAP] (Consolidated)
For the third quarter of the fiscal year ending March 2026, net sales were JPY 290.774 billion (3.6% decrease YoY), operating income was JPY 18.198 billion (54.0% increase YoY), and net income attributable to owners of the parent for the...
Read more -
Fiscal Year 2025 (Ending March 2026) 3rd Quarter Financial Results Presentation Materials
Operating income for the 3rd quarter of fiscal 2025 was 18.2 billion yen, up 6.4 billion yen year-over-year, and net income was 5.5 billion yen, up 3.0 billion yen year-over-year. Despite the impact of the DPE suspension of operations, overall...
Read more -
Notice Regarding Changes to Executive Officers
Promotions, new appointments, retirements of executive officers and organizational restructuring of the technical corporate division effective April 1, 2026.
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥3,384
Rating Score: 1.86 (Based on 7 analysts)
※1=Strong Buy, 5=Strong Sell
Denka Revamps Mission 2030 Plan to Rebuild Earnings and Enter New Growth Phase - TipRanks ↗
Company Information
About
Denka Company Limited manufactures and sells organic and inorganic, electronic material, pharmaceutical, and resin-related products in Japan, rest of Asia, and internationally. It operates through Electronic & Innovative Products; Life Innovation; Elastomers & Infrastructure Solutions; Polymer Solutions; and Other Business segments. The Electronic & Innovative Products segment manufactures and sells electronic packaging materials, fine and functional ceramics, fused silica, acetylene black, electronic circuit substrates, industrial tapes, functional films, spherical alumina, electrical constructional materials, adhesives, adhesive and electrical tapes, monosilane gas, and semiconductor processing materials. Its Life Innovation segment develops influenza vaccines, antigen testing kits, diagnostic reagents, and oncolytic virus agents. The Elastomers & Infrastructure Solutions segment produces functional elastomers, such as chloroprene rubber; cement; special cement additives; fire resistant and environmental materials; construction chemicals; alumina fibers; fused phosphate fertilizers, as well as humic acid magnesium and liquid fertilizers; calcium carbide; and polyethylene corrugated pipes. Its Polymer Solutions segment consisting of styrene monomers, polystyrene and ABS resins, transparent and heat-resistant resins, resins for shrink labels, food packaging sheets and films, synthetic fibers for wigs, POVAL, and CLEAREN. The Other Business segment engages in plant engineering and trading businesses. The company was formerly known as Denki Kagaku Kogyo Kabushiki Kaisha and changed its name to Denka Company Limited in October 2015. Denka Company Limited was incorporated in 1915 and is headquartered in Chuo, Japan.